COVI-VAC

N/A

Report date: 2025/02/14 20:00:40

Base Information

Drug NameCOVI-VAC
Drug Alias NameCoviLivTM2019-nCoV vaccine(Codagenix/Serum Institute of India)Coronavirus vaccine (Codagenix/Serum Institute of India)COVID-19 vaccine(Codagenix/Serum Institute of India)SARS-CoV-2 Vaccine(Codagenix/Serum Institute of India) +[7] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Severe Acute Respiratory SyndromePneumonia, Viral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryVietnamUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCodagenix IncSerum Institute Of India Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCodagenix IncInstitute Of Vaccines And Medical Biologicals, Vietnam
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Severe Acute Respiratory SyndromePneumonia, Viral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A